return to news
  1. Deepak Nitrite Q4: Profit falls 21% YoY to ₹254 crore, board recommends ₹7.5 final dividend

Market News

Deepak Nitrite Q4: Profit falls 21% YoY to ₹254 crore, board recommends ₹7.5 final dividend

Upstox

2 min read | Updated on May 28, 2025, 19:35 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Deepak Nitrite’s revenue from the advanced intermediates segment fell 2.55% YoY to ₹653.94 crore, as against ₹671.07 crore. However, it generated ₹1,532.27 crore from the phelonics segment, up by 4.51% YoY from ₹1,466.11 crore.

Stock list

Deepak Nitrite's board of directors recommended a final dividend of ₹7.50 per 13.64 crore equity share for FY25. | Image: Shutterstock

Deepak Nitrite's board of directors recommended a final dividend of ₹7.50 per 13.64 crore equity share for FY25. | Image: Shutterstock

Deepak Nitrite Q4: Deepak Nitrite on Wednesday, May 28, reported a 20.72% year-on-year (YoY) decline in its consolidated net profit to ₹202.41 crore, compared to ₹253.8 crore in the corresponding period a year earlier.

The profit for the period was affected by headwinds from geopolitical tensions, elevated input prices and oversupply from China, the firm stated.

In the fourth quarter of FY25, the chemical company’s revenue from operations stood at ₹2,179.69 crore, rising 2.52% YoY from ₹2,126.21 crore in Q4FY24. Deepak Nitrite’s revenue from its advanced intermediates segment plunged 2.55% YoY to ₹653.94 crore, as against ₹671.07 crore. However, it generated ₹1,532.27 crore from the phelonics segment, up by 4.51% YoY from ₹1,466.11 crore.

The company’s EBITDA (earnings before interest, tax, depreciation and amortization) was at ₹339 crore in the quarter under review, up by 6% YoY from ₹320 crore in the year-ago period.

Commenting on the results, Deepak C Mehta, Chairman and MD of Deepak Nitrite, said: “This year also marks our renewed vigor and energy in creating the new Deepak. As technology gets signed up, project activities at the new site start taking shape and our relationships with new customers in material sciences would pick up.”

“Our growth plan envisages the development of further upstream products like Nitric Acid and downstream products such as MIBK, MIBC, for which capacities are set to be operationalized in the upcoming quarters. These will deepen the degree of integration across our business and strengthen our competitive position,” he added.

“The plan to manufacture polycarbonate resins is also taking more concrete shape and the board of DCTL has recently approved investments for manufacturing 300 KTA of Phenol, 185 KTA of Acetone and 100 KTA of Isopropyl Alcohol (IPA), including greenfield infrastructure capex for an aggregate investment of about 3,500 Crores,” he said.

“This is over and above the present manufacturing capacity of these productsand the new capacity of Phenol and Acetone will be ultimately integrated to produce Polycarbonate Resins. This approval, along with the previous approval of 5,000 crores of PC resins, brings the aggregate investment pipeline for the PC Resin project to ~ 8,500 crores,” Mehta stated.

Deepak Nitrite's board of directors recommended a final dividend of ₹7.50 per 13.64 crore equity share (375%) with a face value of ₹12 each for the year. It is subject to shareholder approval.

SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.